Multiomics and Transplant Medicine – Interview with Professor Brendan Keating on Translating Proteomics
Nautilus Biotechnology
October 15, 2026
Professor Brendan Keating’s lab focuses on “advancing the field of organ transplantation” and employs multiomic techniques to improve outcomes for both allo- (human to human) and xeno- (animal to human) transplantation. He’s using multiomics to better understand the mechanisms of rejection and acceptance with a particular focus on immunologic barriers in cross-species transplantation. Professor Keating joins Translating Proteomics to discuss:
- The current state of transplant medicine including xenotransplantation.
- How multiomics is changing transplant medicine.
- The future of transplant medicine.
Stream the episode on Apple Podcasts, Spotify, or YouTube.
Chapters:
00:00 – Introduction
05:00 – Transplantation Today: Outcomes, Challenges, and the Organ Shortage
10:06 – From Genetics to Multiomics
19:53 – Xenotransplantation deep dive
30:42 – Ten‑Year Vision: Transplants and the Role of Multiomics
MORE ARTICLES